TRACON PHARMACEUTICALS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TCON and buy or sell other stocks, ETFs, and their options commission-free!

About TCON

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. 

CEO
Craig R. Jalbert
CEOCraig R. Jalbert
Employees
Employees
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2004
Founded2004
Employees
Employees

TCON Key Statistics

Market cap
109.72K
Market cap109.72K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
9.02K
Average volume9.02K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$14.75
52 Week high$14.75
52 Week low
$0.002
52 Week low$0.002
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.